RT Book, Section
A1 Usatine, Richard P.
A1 Sabella, Camille
A1 Smith, Mindy Ann
A1 Mayeaux, E.J.
A1 Chumley, Heidi S.
A1 Appachi, Elumalai
SR Print(0)
ID 1114874228
T1 Acneiform Disorders
T2 The Color Atlas of Pediatrics
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-176701-9
LK accesspediatrics.mhmedical.com/content.aspx?aid=1114874228
RD 2024/04/20
AB References1Purdy  S,  de  Berker  D.  Acne  vulgaris.  Clin  Evid  (Online).  2011  Jan  5;2011.  pii:1714.2Smith  EV,  Grindlay  DJ,  Williams  HC.  What’s  new  in  acne?  An  analysis  of  systematic  reviews  published  in  2009-  2010.  Clin  Exp  Dermatol.  2011;36:119–122.20738323[PubMed:  ]3Strauss  JS,  Krowchuk  DP,  Leyden  JJ,  et  al.  Guidelines  of  care  for  acne  vulgaris  management.  J  Am  Acad  Dermatol.  2007;56:651–663.17276540[PubMed:  ]4Shirakawa  M,  Uramoto  K,  Harada  FA.  Treatment  of  acne  conglobata  with  infliximab.  J  Am  Acad  Dermatol.  2006;55:344–346.16844527[PubMed:  ]5Grunwald  MH,  Amichai  B.  Nodulo-cystic  eruption  with  musculoskeletal  pain.  J  Fam  Pract.  2007;56:205–206.17343810[PubMed:  ]6AHRQ.  Management  of  Acne.  http://www.ahrq.gov/clinic/epcsums/acnesum.htm  [serial  online].  2001.7Draelos  ZD,  Carter  E,  Maloney  JM,  et  al.  Two  randomized  studies  demonstrate  the  efficacy  and  safety  of  dapsone  gel,  5%  for  the  treatment  of  acne  vulgaris.  J  Am  Acad  Dermatol.  2007;56:439–410.17208334[PubMed:  ]8Webster  GF,  Guenther  L,  Poulin  YP,  et  al.  A  multicenter,  double-blind,  randomized  comparison  study  of  the  efficacy  and  tolerability  of  once-daily  tazarotene  0.1%  gel  and  adapalene  0.1%  gel  for  the  treatment  of  facial  acne  vulgaris.  Cutis.  2002;69(2  Suppl):4–11.12095066[PubMed:  ]9Garner  SE,  Eady  EA,  Popescu  C,  et  al.  Minocycline  for  acne  vulgaris:  efficacy  and  safety.  Cochrane  Database  Syst  Rev.  2003;  CD002086.10Maleszka  R,  Turek-Urasinska  K,  Oremus  M,  et  al.  Pulsed  azithromycin  treatment  is  as  effective  and  safe  as  2-week-longer  daily  doxycycline  treatment  of  acne  vulgaris:  a  randomized,  double-blind,  noninferiority  study.  Skinmed.  2011;9:86–94.21548512[PubMed:  ]11Enshaieh  S,  Jooya  A,  Siadat  AH,  Iraji  F.  The  efficacy  of  5%  topical  tea  tree  oil  gel  in  mild  to  moderate  acne  vulgaris:  a  randomized,  double-blind  placebo-controlled  study.  Indian  J  Dermatol  Venereol  Leprol.  2007;73:22–25.17314442[PubMed:  ]12Karvonen  SL.  Acne  fulminans:  report  of  clinical  findings  and  treatment  of  twenty-four  patients.  J  Am  Acad  Dermatol.  1993;28:572–579.7681856[PubMed:  ]13Seukeran  DC,  Cunliffe  WJ.  The  treatment  of  acne  fulminans:  a  review  of  25  cases.  Br  J  Dermatol.  1999;141:307–309.10468806[PubMed:  ]14Tanghetti  E,  Dhawan  S,  Green  L,  et  al.  Randomized  comparison  of  the  safety  and  efficacy  of  tazarotene  0.1%  cream  and  adapalene  0.3%  gel  in  the  treatment  of  patients  with  at  least  moderate  facial  acne  vulgaris.  J  Drugs  Dermatol.  2010;9:549–558.20480800[PubMed:  ]15Leyden  J,  Thiboutot  DM,  Shalita  AR,  et  al.  Comparison  of  tazarotene  and  minocycline  maintenance  therapies  in  acne  vulgaris:  a  multicenter,  double-blind,  randomized,  parallel-group  study.  Arch  Dermatol.  2006;142:605–612.16702498[PubMed:  ]16Yeung  CK,  Shek  SY,  Bjerring  P,  et  al.  A  comparative  study  of  intense  pulsed  light  alone  and  its  combination  with  photodynamic  therapy  for  the  treatment  of  facial  acne  in  Asian  skin.  Lasers  Surg  Med.  2007;39:1–6.17252567[PubMed:  ]17Wiegell  SR,  Wulf  HC.  Photodynamic  therapy  of  acne  vulgaris  using  5-aminolevulinic  acid  versus  methyl  aminolevulinate.  J  Am  Acad  Dermatol.  2006;54:647–651.16546587[PubMed:  ]18Horfelt  C,  Funk  J,  Frohm-Nilsson  M,  et  al.  Topical  methyl  aminolaevulinate  photodynamic  therapy  for  treatment  of  facial  acne  vulgaris:  results  of  a  randomized,  controlled  study.  Br  J  Dermatol.  2006;155:608–613.16911289[PubMed:  ]